The global qPCR instruments market is on a growth trajectory, with a projected value of USD 1.3 Billion in 2023. According to a newly released report from Future Market Insights, the market is expected to expand at a Compound Annual Growth Rate (CAGR) of 3.5% from 2023 to 2033, with forecasts indicating it will reach USD 1.8 Billion by the end of the forecast period.
Chronic diseases, viral sicknesses, and hereditary problems like Alzheimer’s, Turner disorder, and Parkinson’s have expanded in commonness, which is projected to drive market extension. Ongoing illnesses like malignant growth, diabetes, kidney sickness, and respiratory issues, including asthma, represent seven out of 10 fatalities in the United States every year, as per the CDC. With PCR, illnesses can be recognized all the more rapidly, considering more convenient and reasonable treatments.
The market is projected to ascend as qPCR innovation becomes more widely adopted. Because of their accuracy, computerization, careful outcomes, continuous measurement, and awareness, qPCR methods are turning out to be more well-known. Since qPCR acknowledges a wide range of nucleic acids as inputs, it is a successful and important technique in research.
By enhancing little objective particles a few times throughout a brief timeframe, qPCR Instruments help in the distinguishing identification of small target molecules. qPCR instruments are broadly used across several applications, including quality articulation examination, genotyping, and epigenetics research. They are likewise helpful in the disclosure of new prescriptions as they can be utilized to evaluate mRNA levels or recognize transformations connected to illnesses like malignant growth.
For the production of novel meds, the qPCR instrument is utilized. qPCR instruments can be utilized to decide the amount of quality or mRNA available in a cell. A suitable test is utilized to make these estimations. Researchers can utilize the information given by this system to more readily comprehend how qualities work all through sickness processes and to assemble more successful therapies.
North America accounted for a significant share of the market and is expected to grow at a CAGR of 3.6% during the forecast period. The growing administrative support and expanding dispatches of novel medicines are responsible for the development of the regional market.
Key Takeaways:
- Global Market Growth: The global qPCR instruments market is projected to reach USD 1.3 billion in 2023, with a steady growth forecast of 3.5% CAGR from 2023 to 2033, reaching an estimated USD 1.8 billion by 2033.
- USA Market Outlook: The USA is expected to lead the market with a CAGR of 3.7%. The market’s growth is driven by administrative support and the increasing deployment of new drug therapies.
- United Kingdom Market Growth: The UK qPCR instruments market is forecast to reach USD 72.9 million by 2033, growing at a CAGR of 3.8%, offering an absolute dollar opportunity of approximately USD 22.6 million.
- Japan Market Expansion: Japan’s qPCR instruments market is projected to grow at a CAGR of 4.2%, reaching USD 76.4 million by 2033. It will offer an absolute dollar opportunity of USD 25.8 million during the forecast period.
- South Korea Market Prospects: South Korea is expected to see a market valuation of USD 39.4 million by 2033, with a CAGR of 4%. The market will provide an absolute dollar opportunity of around USD 12.7 million.
Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!
Competitive Landscape:
The key players operating in the market include Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Abbott, Qiagen, Azure Biosystems Inc., and Quantabio.
- In November 2020, Streck launched its Zulu RT, qPCR instrument. This can be utilized to perform four trials simultaneously and autonomously. The more prominent adaptability of this instrument was supposed to assist capture a share of the market.
Market Segments Covered in qPCR Instruments Industry Analysis
By Instrument Type:
- 7500
- QuantStudioDx Real-Time PCR System
- QuantStudio 5 Real-Time PCR System
- ViiA 7 Dx
- StepOne/ StepOne Plus
- LightCycler 2.0/ 96/ 480/ 1536
- Cobas 4800
- SmartCycler
- GeneXpert
- Rotor-Gene Q 5Plex HRM System
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
